Biopharma Business

Tag "Zebinix"

EMA approves once-daily therapy for partial-onset epilepsy

    EMA approves once-daily therapy for partial-onset epilepsy

The European Medicines Agency (EMA) has approved Zebinix (eslicarbazepine acetate) for use as once-daily monotherapy to treat adults with newly-diagnosed partial-onset epilepsy. It is already indicated in Europe as an

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements